Alan Kozikowski
Geen lopende functies
Vermogen: 436 545 $ op 30-04-2024
Profiel
Alan P.
Kozikowski was the founder of Actuate Therapeutics, Inc. (founded in 2015) and Bright Minds Biosciences, Inc. (founded in 2019), where he held the title of Director in 2022.
He was the President & Chief Executive Officer of Starwise Therapeutics LLC from 2017 to 2020.
He also held the title of Director-Drug Discovery Program at Georgetown University Medical Center and was a Professor at the University of Pittsburgh.
From 2013 to 2017, he was a Professor-Emeritus at the University of Illinois.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-12-2023 | 400 500 ( 9.27% ) | 436 545 $ | 30-04-2024 |
Eerdere bekende functies van Alan Kozikowski
| Bedrijven | Functie | Einde |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Oprichter | 07-09-2022 |
| Starwise Therapeutics LLC | Algemeen Directeur | 01-02-2020 |
| University of Illinois | Corporate Officer/Principal | 31-07-2017 |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Oprichter | - |
| Georgetown University Medical Center | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Starwise Therapeutics LLC | |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
